These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29511671)

  • 1. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.
    Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W
    Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
    Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
    Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
    Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
    Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
    Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the overexpression of TRAF4 in predicting the prognosis of intrahepatic cholangiocarcinoma.
    Kang Q; Zou H; Zhou L; Liu LX; Cai JB; Xie N; Li WH; Zhang C; Shi WH; Wang LM; Zhang WH; Zhu H; Wang SF; Zhang XW
    Int J Oncol; 2018 Jul; 53(1):286-296. PubMed ID: 29749456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of GLS1 in intrahepatic cholangiocarcinoma and its clinical significance.
    Cao J; Zhang C; Jiang GQ; Jin SJ; Gao ZH; Wang Q; Yu DC; Ke AW; Fan YQ; Li DW; Wang AQ; Bai DS
    Mol Med Rep; 2019 Aug; 20(2):1915-1924. PubMed ID: 31257527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
    Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H
    Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of G
    Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
    Ohashi T; Eguchi H; Kawamoto K; Konno M; Asai A; Colvin H; Ueda Y; Takaoka H; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Kobayashi S; Koseki J; Satoh T; Ogawa K; Doki Y; Mori M; Ishii H
    Oncol Rep; 2018 Mar; 39(3):1276-1282. PubMed ID: 29286150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
    Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
    BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma.
    Zhang C; Bai DS; Huang XY; Shi GM; Ke AW; Yang LX; Yang XR; Zhou J; Fan J
    PLoS One; 2013; 8(1):e54619. PubMed ID: 23349941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
    Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma.
    Sang H; Li T; Li H; Liu J
    Tumour Biol; 2015 Nov; 36(11):8367-77. PubMed ID: 26014518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
    Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
    Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.